The historical development of different techniques for the study of proliferative patterns of normal and malignant tissue is explained. For more than 100 years, pathologists and clinicians have attempted to clarify the prognostic impact of this tumor-biological parameter. One relevant result of these investigations is the 'Grading-System', a histomorphological description of tumor cell differentiation. The autoradiographic method using tritiated thymidine (thymidine incorpora- 
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The historical development of different techniques for the study of and a correlation to the recurrence rate in a series of RCC patients. The main disadvantages of this method, however, involve the extracorporal organ perfusion (ex vivo) required after tumor nephrectomy, the radioactive contamination and waste disposal as well as personal safety, long autoradiographic exposure times and, thus, the lack of practicability of this technique in routine diagnosis [6, 8] . The successful immuno-logical preparation of monoclonal antibodies represented a relevant advance in this field [9] .
DNA-Cytometry for RCC
Single-cell and flow DNA-cyto(photo)metry (e.g. combined with the Feulgen staining) are commonly used techniques for the evaluation DNA-content of malignant of tissue tumors [2] . Formalin-fixed and paraffin-embedded tissue [10] as well as fresh tissue can be analyzed for DNA-cytophotometry [2] . This technique has been used for more than ten years in basic and clinical research. Extensive experience has been achieved by means of this technique: In 1985, Ljungberg was one of the first authors using DNA flow-cytometry on RCC [11] . In 196 analysed tissue samples of 25 cases of RCC, a correlation between DNA distribution (ploidy) and morphologic grading was demonstrated. Tumor proliferation, as determined by the fraction of cells in S-phase, was significantly higher in aneuploid samples compared to normal kidney tissue samples and diploid tumor samples. This paper was the first to describe DNA heterogeneity in RCC caused by different tumor cell clones. To exclude a so-called "sampling error' several biopsies depending on the tumor size must be taken from each tumor [11] . About 40% of the analyzed RCC were aneuploid with a DNA content > 5 C. Different studies confirmed the progno stic importance of this parameter in RCC [12, 13] . The results of both techniques, single-cell and flow DNAcytometry, showed no relevant differences in ploidy heteroge neity and prognostic value of DNA content for RCC patients [14] . The main disadvantage is that this technology requires equip ment for photometric imaging. Due to the expense this equip ment is only available in research and medical centers. Al though it is a valid and reliable parameter in RCC, DNAcytometry did not prove successful in routine diagnostics [15] .
Immunohistochemical Techniques
Bromodeoxyuridine (BrdU) Technique
In order to avoid the problems of the thymidine incorporation assay, several investigators used S-bromo^-deoxyuridine (BrdU), a non-radioactive thymidine analogue which is also incorporated into DNA-synthesizing cells [8, 16, 17, 18, 19] . In 1982, Gratzner et al. isolated and described a monoclonal antibody (mab) against BrdU [20] which allows for the rapid detection of BrdU-laden cells in vivo and in vitro as well as by immunohistochemical techniques [21] . Although BrdU immunohistochemistry solves many of the problems associated with [ 3 H]-Thd in cell kinetics studies (as outlined above), its use generates the following problems: BrdU is a cytotoxic substance. Administrations of BrdU at high doses have been shown to be mutagenic in vitro and carcinogenic in vivo in an animal model [22] . BrdU also inhibits cell differentiation and thymidine uptake in vitro, as well as DNA synthesis and cell replication in both in vitro and in vivo settings [8] . Whether or not these negative aspects of BrdU administration affect the results compiled by in-vivo cell kinetic studies, remains un clear. Due to the mutagenic and carcinogenic potentials, BrdU can only be used for animal and in-vitro studies, but not for direct in-vivo determination of proliferative cell fractions in human malignancies. Therefore, the BrdU immunohistochem istry represents an indirect method only to assess the prolifera tion rates in human neoplasms.
Ki-67 Staining
In 1983, Gerdes et al. isolated and characterized a human nuclear antigen (termed k Ki-67') present in DNA-synthesizing cells only [23] ; its expression is observed in normal as well as in malignant cells but is absent in resting cells [24] . Figure 1 illustrates this schematically for the different phases of cell division [24] . Using frozen sections and immunhistochemical staining techniques as outlined by Gerdes [25] and Cordell [26] , individual in-vivo proliferation rates can now be obtained directly in normal and malignant tissue as well ( fig. 2 ). Ki-67 is a mouse monoclonal antibody which binds to a human nuclear antigen associated with cell proliferation [23, 24] . Cell cycle analyses demonstrated that the nuclear antigen detected by Ki-67 is only expressed in the G { , S, G 2 and Μ phases of proliferating cells, normal as well as malignant, but is absent in resting cells (G 0 ) ( fig. 1) [24, 25] . Immunostainings with Ki-67 revealed nuclear reactivity in cells of germinal centres of cortical follicles, cortical thymocytes, neck cells of gastroin testinal mucosa, undifferentiated spermatogonia and cells of a number of human cell lines. The Ki-67 antibody did not react with cells known to be in a resting stage such as lymphocytes, monocytes, parietal cells and Panetlrs cells of gastrointestinal mucosa, hepatocytes, normal renal cells, mature sperm cells and brain cells [23] . Expression of this antigen recognized by Ki-67 could be induced in peripheral blood lymphocytes after Ki-67 staining is performed as follows: Tissue biopsies must be stored in fluid nitrogen to get 5μ frozen sections for the immunohisiochemical staining; formalin fixed samples are not suitable [25] . As recently described, growth fractions of cultur ed tumor cells can also be immunocytochemically determined on special slide chambers [15, 31] .
Ki-67 staining is delineated schematically in figure 2: The acetone-and chloroform-fixed cells (in vivo: 5μ frozen sec tions; in vitro: eel's are directly attached on the slides [15] ) are exposed for approximately 30 minutes to the monoclonal antibody (Ki-67) which has been diluted in RPMI 1640 me dium. Afier washing in TRIS-buffered solution (pH 7.4 -7.6), the cells are incubated with rabbit-anti-mouse IgG and then exposed :o APAAP (alkaline phosphatase anti-alkaline pho sphatase) complex after repeated washing [26] . Subsequently, the slides are stained with 'Fast Red' and counter/stained with hemalum [25, 31] . Presence of the specific proliferation-asso ciated nuclear antigen is indicated by a red instead of a blue color reaction after counterstaining ( fig. 3,4) . Different human malignancies have already been investigated using the Ki-67 immunohistochemistry [1, 2, 15, 27, 29, 30, 32, 33, 34, 35] : The in vivo proliferation rate of RCC is low, only ranging up to 25% [15, 36] . Because of this low proliferative potential, only a few mitotic cells can be obtained by biopsy.
For that reason, direct karyotyping of the cells is impaired by irregular contractions of the chromosomes [37, 38, 39] . There fore, reports on the chromosomal features of RCC are rare. Yoshida et al [39] were among the first to karyotype malignant renal cells after short-term in vitro culturing. During short-term in vitro culturing, the proliferation rates of
• Γ. fr--* . malignant renal cells increase up to 85%. This phenomenon improves the cytogenetical output [15] . Malignant renal cells prepared in vitro in the manner as recently described were characterized by employing conventional cytological, cytochemical and immunocytochemical measures [40] : Malignant re nal cells were exclusively obtained by the cell-cluster prepara tion technique [7] . Aberrations on the short (p) arm of chro mosome 3 were the most common cytogenetic finding (77.8%) in 36 cases of non-familial RCC. It seems that this chromoso mal defect is the initial cytogenetic change and that it triggers genetic instability during the clonal development and progres sion of human RCC [7, 15] . These connected findings could be appropriately verified by the described Ki-67 immunostaining assay [15] . There are different methods to determine the percentage of Ki-67-positive cells; one is described by Gerdes [25] . In recent years, the immunostaining quantitative analysis has been done by means of a computer-assisted image processor configured with a standard microscope [27] . The highest proliferation rate found for all specimens in a given case is considered to be representative of the entire tumor. To exclude sampling errors in the determination of the tumor-specific proliferation rate, several samples of solid tumor tissue must be obtained, depen ding on the individual tumor size (table 1) [15] . This experien ce is also described in other maligant soft tissue tumors, taking into account that several biopsies are necessary to obtain the intratumoral variability [27] . As illustrated in figure 5 , fresh tumor tissue must be stored immediately in fluid nitrogen for correct and reliable determi nation of the tumor-specific proleferation rate [15] . Rates measured 3.5 h after tumor nephrectomy amounted to only approximately 50% of those initially determined [15] . This observation correlates with in vitro growth rates of tumor cells, which depend essentially on the interval between ne phrectomy, tissue sampling and fresh tissue preparation [40. 41] .
Tumor infiltrating lymphocytes often observed in the periphe ral zones of RCC should be excluded in the immunohistochemical Ki-67 evaluation. These lymphcytes exhibit cell prolife ration within the tumor which are obviously caused by lymphokines and can therefore simulate higher proliferation rates of the tumor. For this reason, reference slides of each biopsy must be taken for conventional histological examina tion to exclude this phenomenon on frozen sections; histologi cal differentiation between lymphocytes and tumor cells is almost impossible on frozen sections alone [15] . Confirming the data published by Rabes et al. [5, 6] , higher proliferation rates were always measured in the peripheral zones of the tumors as compared with central zones [15] . This is obviously nutrition-related due to better blood circulation in the peripheral areas. According to these findings, it is obvious that necroses and cysts initially develop in the central zones of renal tumors, a phenomenon often observed macroscopically [42] . Urological and other solid human malignancies exhibited simi lar proliferation rates (defined by the mab Ki-67) to those already mentioned for RCC [15, 36] 
Breast cancer:
Low-grade tumors: 2%-12%. High-grade tumors: 13%-20% [28. 54, 35] . Up to now, only a few papers have dealt with the tumorspecific Ki-67 determination in RCC [15, 36, 43, 44] , revealing a correlation between proliferation rates and histological gra ding, but almost no correlation with tumor stage. The individual tumor stage cannot be concluded from the proliferation status, as it is a function of cell proliferation as well as of the time of tumor growth, the latter parameter not being measureable at the time of diagnosis. Some large RCC exhibited low proliferation rates, where as low-stage tumors (pT|_2 : 2-4cm in diameter) were found to vary 5-fold in proliferation rates [15] . These data explain the clinical obser vation in cases of RCC in which, despite a non-surgical ap proach for various reasons, an almost proliferative arrest was noted at long-term follow-up [45] . On the other side unusual growth rates of low-stage were observed by imaging techni ques (CT, sonography) [46, 47] . A similiar correlation is found in other malignancies using the Ki-67 immunohistochemistry revealing a correlation between proliferation status and tumor grading, but no correlation with tumor stage [2, 28, 34, 35] . Only a few authors have outlined the correlation of prolifera tive behavior of different malignancies and prognosis. Measu rement of the individual proliferation status appears to be an additional diagnostic parameter for the detection of RCC patients at high risk, especially in the early stages showing identical histological features [15, 36, 43, 44] . In breast cancer, the immunohistochemical Ki-67 parameter was found to be an additional independent prognostic parame ter beyond conventional histologial staging and grading [28, 34] . Further investigations are necessary to study immunohi stochemistry and long-term follow-up of patients to confirm this preliminary experience.
Comparative studies verified the equivalence of DNA cytome try and immunhistochemical Ki-67 index in assessing the proli ferative cell fraction of normal and malignant tissue [2] . Be cause immunohistochemical staining techniques are employed in almost all pathological institutions, the Ki-67 staining assay will, in the future, most probably be used for routine histologi cal diagnostics. Immunhistochemical determination of tumorspecific proliferation rates using the monoclonal antibody (mab) T is a practicable, reproducible and reliable method to obtain the proliferative pattern of RCC and other human malignancies. It may be important for the detection of highrisk patients and, conclusively, for prognosis.
